2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL
Market cap: $332.2M (12/29/2025)
Price: $4.53
Board Approves Amended Employment Agreements for Executive Officers
Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates
Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
Unlocking Life Changing Therapies September 2025
Regains Compliance with Nasdaq Minimum Bid Price Requirement
Unlocking Life Changing Therapies August 2025
Reg. FD
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Free Writing Prospectus
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement